Skip to content
MarketScale
‹ Back to IndustriesSciences

On the way to Space, Billionaires Look for Business Partners

The world is in a new space race. This time, though, it is not the United States versus the Soviet Union; instead, it is Jeff Bezos versus Richard Branson versus Elon Musk. This billionaire space race, as it is being called, has resulted in the creation of just as many companies. Musk’s SpaceX and Branson’s…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Troy Camplin · BezosBlue OriginElon MuskScience
Share
On the way to Space, Billionaires Look for Business Partners

Key takeaways

01

The world is in a new space race.

02

This time, though, it is not the United States versus the Soviet Union; instead, it is Jeff Bezos versus Richard Branson versus Elon Musk.

03

This billionaire space race, as it is being called, has resulted in the creation of just as many companies.

Get featured

Want to get featured in MarketScale Sciences?

Create a free MarketScale workspace and get your company's expertise featured across our Sciences coverage. No credit card, no demo required.

Request an invite

The world is in a new space race. This time, though, it is not the United States versus the Soviet Union; instead, it is Jeff Bezos versus Richard Branson versus Elon Musk.

This billionaire space race, as it is being called, has resulted in the creation of just as many companies. Musk’s SpaceX and Branson’s Virgin Galactic may grab the headlines, but there is also Bezos’ Blue Origin, and Milner’s Breakthrough Starshot. The late Paul Allen also started Stratolaunch.

Each is aimed at somewhat different aspects of space travel, but one thing they all have in common is a competitive—and cooperative—spirit that is driving a great deal of technical innovation.

Companies like SpaceX are finding that it is important to partner with other companies to be successful. NASA and companies like Iridium have partnered with SpaceX to put satellites in orbit. Land Rover and Abu Dhabi, meanwhile, have chosen to partner with Virgin Galactic, who is also partnering with Boom Technology to create a supersonic passenger transporter. While SpaceX has NASA, Blue Origin is partnered with the Air Force for launch services.

There is a healthy need for space services and for creating strong partnerships to develop the technology needed, but what new technologies are on the horizon?

SpaceX has been having more and more success with its rockets, and it famously was able to land a rocket on a sea platform. Elon Musk has also been talking about going to Mars, and that will take some serious improvements in technology. In fact, SpaceX is currently working with NASA on developing a Mars-landing mission.

Blue Origin has developed New Shepard, a suborbital, reusable launch vehicle, and New Glenn, an orbital, reusable launch vehicle.

Virgin Galactic has long talked about the creation of a space plane that will make space tourism feasible. On Dec. 13, Virgin Galactic came a lot closer to realizing that dream when it was able to fly its VSS Unity to the edge of space.

With plans for the moon and Mars, including the possibility of 3D printing structures for people to potentially visit or inhabit, the sky is absolutely not the limit for these visionaries. While the space race between the USA and the USSR got man into space in the first place, and even placed a few men on the moon, the billionaires’ space race looks to take space technology, research, and exploration to new heights. Only time will tell what benefits all of this will bring.

For the latest news, videos, and podcasts in the Science Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – twitter.com/ScienceMKSL

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

TC
Troy Camplin

Follow Sciences Insights

Get new expert content in your inbox.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free plan

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Sciences Insights

Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply

Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply

Resilience and Eli Lilly are investing $750 million to expand KwikPen injectable device production at Resilience's Cincinnati-region manufacturing facility, expected to create 400 high-skilled jobs and reach full operations by early 2027. The partnership builds on their collaboration since 2023, which has already produced over 150 million doses of Lilly medications for the U.S. market.

  • 01$750 million investment to expand Resilience's Ohio manufacturing capacity for Eli Lilly's KwikPen injectable device production
  • 02400 new high-skilled jobs expected in Cincinnati region, with full operations by early 2027
  • 03Partnership has already produced over 150 million doses of Lilly medications for the U.S. market since 2023

Sep 14, 2026

ENEOS ran an AI controller on a distillation column for 35 days and cut steam use 40%

ENEOS ran an AI controller on a distillation column for 35 days and cut steam use 40%

ENEOS Materials and Yokogawa ran an autonomous AI controller on a butadiene distillation column for 35 days and cut steam use 40%. It’s a real operations proof point. It also puts integration and governance gaps front and center.

  • 01A 35-day closed-loop run is a stronger autonomy proof point than a demo, it forces plants to prove handover, fallback, and KPIs over real feed and operating swings.
  • 02Steam reduction claims are compelling, but procurement and ops teams should pin vendors to baselines, operating envelopes, and how off-spec avoidance is measured.
  • 03Agentic AI is showing up as “work management” and “shift checklist” agents before it replaces control engineers, which shifts requirements toward clean, permissioned data access.

Sep 13, 2026

Novaspace sees 6,500+ Earth observation satellites by 2035, and value shifts to payload integration

Novaspace sees 6,500+ Earth observation satellites by 2035, and value shifts to payload integration

Novaspace forecasts more than 6,500 Earth observation satellites launching by 2035. It also projects $155.9 billion in manufacturing revenue, based on a SpaceNews-posted release dated Aug. 21, 2026. As defense-led demand shifts toward revisit rate and persistence, payload integration and fleet interoperability become the hard parts.

  • 01$155.9 billion is tied specifically to satellite manufacturing, not launch or ground, which should reshape how teams size supplier commitments and make-buy decisions.
  • 02Novaspace’s “skyscraper model” framing implies procurement power is shifting to payload integration, test capacity, and software-defined operations, even as the bus becomes more standardized.

Sep 13, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

TC
Troy Camplin

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512